Cytovene IV is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by H2-pharma, Llc. The primary component is Ganciclovir Sodium.
Product ID | 61269-450_21f3f765-c9da-4d2a-a0b2-f3af9a25ffc4 |
NDC | 61269-450 |
Product Type | Human Prescription Drug |
Proprietary Name | Cytovene IV |
Generic Name | Ganciclovir Sodium |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1989-06-23 |
Marketing Category | NDA / NDA |
Application Number | NDA019661 |
Labeler Name | H2-Pharma, LLC |
Substance Name | GANCICLOVIR SODIUM |
Active Ingredient Strength | 500 mg/10mL |
Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1989-06-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019661 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1989-06-23 |
Ingredient | Strength |
---|---|
GANCICLOVIR SODIUM | 500 mg/10mL |
NDC | Brand Name | Generic Name |
---|---|---|
0004-6940 | Cytovene | ganciclovir sodium |
61269-450 | Cytovene | ganciclovir sodium |
0143-9299 | Ganciclovir | Ganciclovir sodium |
14335-030 | Ganciclovir | ganciclovir sodium |
25021-185 | ganciclovir | ganciclovir sodium |
51817-171 | Ganciclovir | ganciclovir sodium |
63323-315 | Ganciclovir | GANCICLOVIR SODIUM |
70436-089 | Ganciclovir | ganciclovir sodium |
76233-072 | Ganciclovir | Ganciclovir Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CYTOVENE 73632978 1444841 Live/Registered |
SYNTEX (U.S.A.) INC. 1986-11-28 |